Trial Profile
A prospective, observational, single cohort study of adalimumab in patients with rheumatic arthritis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 Aug 2016
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms ANOUVAEU study
- 12 Aug 2016 New trial record